Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €88.00 ($103.53) price target from stock analysts at Independent Research GmbH in a research note issued to investors on Friday. The firm presently has a “neutral” rating on the stock. Independent Research GmbH’s price objective would suggest a potential upside of 6.73% from the company’s current price.

FME has been the topic of a number of other reports. Berenberg Bank set a €95.60 ($112.47) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Tuesday, September 5th. J P Morgan Chase & Co set a €95.10 ($111.88) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Thursday, September 14th. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Monday. Finally, Morgan Stanley set a €90.00 ($105.88) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a report on Friday, September 15th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and nine have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of €89.12 ($104.84).

ILLEGAL ACTIVITY WARNING: This report was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.americanbankingnews.com/2017/11/03/independent-research-gmbh-analysts-give-fresenius-medical-care-ag-88-00-price-target.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.